mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapy

Breast Cancer Research and Treatment

Volumn 45, Issue 1, 1997, Pages 63-74

  Wang, Chang Shu ^a   LaRue, Hélène ^a   Fortin, André ^a   Gariépy, Gilles ^b   Têtu, Bernard ^a,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b Hôpital Saint Luc   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Breast cancer; mdr1; Multidrug resistance; Neoadjuvant chemotherapy and hormone therapy; P glycoprotein

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GLYCOPROTEIN P; MESSENGER RNA; MONOCLONAL ANTIBODY; TAMOXIFEN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BETA 2-MICROGLOBULIN; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; GENE EXPRESSION; GENES, MDR; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, ESTROGEN; RNA, MESSENGER; TREATMENT FAILURE;

EID: 0030751798     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005824704740     Document Type: Article

References (45)

1. Auclerc G, Borel C, Khayat D, Soubrane C, Weil M: La chimiothérapie première dans le traitement du cancer du sein. Ann Chir Plast Esthet 37: 663-669, 1992
2. Powles TJ, Hickish TF, Makris A, Ashley SE: Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 13: 547-552, 1995
3. Bonadonna G, Valagussa P, Brambilla C, Ferrari L: Preoperative chemotherapy in operable breast cancer. Lancet 341: 1485, 1993
4. Smith IE, Jones AL, O'Brien ME, McKinna JA, Sacks N, Baum M: Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. Eur J Cancer 29a: 1796-1799, 1993
5. Anderson ED, Forrest AP, Hawkins RA, Anderson TJ, Leonard RC, Chetty U: Primary systemic therapy for operable breast cancer. Br J Cancer 63: 561-566, 1991
6. Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Greco M, Bartoli C, Coopmans de Yoldi G, Zucali R, Rilke F, Andreola S, Silvestrini R, diFronzo G, Valagussa: Primary chemotherapy to avoid mastectomy with diameters of three centimeters or more. J Natl Cancer Inst 82: 1539-1545, 1990
7. Jacquillat C, Weil M, Baillet F, Borel C, Auclerc G, de Maublanc MA, Housset M, Forget G, Thill L, Soubrane C, Khayat D: Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 66: 119-129, 1990
8. Chan HSL, Thorner PS, Haddad G, Ling V: Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8: 689-704, 1990
9. Epstein J, Xiao H, Oba BK: P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VAD. Blood 74: 913-917, 1989
10. Ma DDF, Daver RA, Harman DH, Isbister JP, Scurr RD, Mackertich SM, Dowden G, Bell DR: Detection of a multidrug resistance phenotype in acute non-lymphoblaslic leukaemia. Lancet 1: 135-137, 1987
11. Merkel DE, Fuqua SAW, Tandon AK, Hill SM, Buzdar AU, McGuire WL: Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J Clin Oncol 7: 1129-1136, 1989
12. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR: Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38: 1277-1287, 1990
13. Ro J, Sahin A, Ro JY, Fritsche H, Hortobagyi G, Blick M: Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. Hum Pathol 21: 787-791, 1990
14. Charpin C, Vielh P, Duffaud F, Devictor B, Andrac L, Lavaut MN, Allasia C, Horschowski N, Piana L: Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators. J Natl Cancer Inst 86: 1539-1545, 1994
15. Wishart GC, Plumb JA, Going JJ, McNicol AM, McArdle CS, Tsuruo T: P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer 62: 758-761, 1990
16. Schneider J, Bak M, Efferth Th, Kaufmann M, Mattern J, Volm M: P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer 60: 815-818, 1989
17. Weinstein RS, Hansen KK, McBeath RB, Dalton WS: Expression of the MDR1 gene (P-glycoprotein) in breast cancer. Recent Results in Cancer Res 127: 49-54, 1993
18. Verrelle P, Meissonnier F, Fonck Y, Feillel V, Dionet C, Kwiatkowski F, Plagne R, Chassagne J: Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast cancer. J Natl Cancer Inst 83: 111-116, 1991
19. Chevillard S, Pouillart P, Beldjord C, Asselain B, Beuzeboc P, Magdelénat H, Vielh P: Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. Cancer 77: 292-300, 1996
20. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I: Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116-124, 1989
21. Keith WN, Stallard S, Brown R: Expression of mdr1 and gst-π in human breast tumours: comparison to in vitro chemosensitivity. Br J Cancer 61: 712-716, 1990
22. Kacinski BM, Yee LD, Carter D: Quantitation of tumor cell expression of the P-glycoprolein (mdr1) gene in human breast carcinoma clinical specimens. Cancer Bull 41: 44-48, 1989
23. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Azdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson I: Quantitative analysis of mdr (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164, 1990
24. Hennequin E, Delvincourt C, Pourny C, Jardillier JC: Expression of mdr1 gene in human breast primary tumors and metastases. Breast Cancer Res Treat 26: 267-274, 1993
25. Moscow JA, Fairchild CR, Madden MJ, Ransom DT, Wienand HS, O'Brien EE, Poplack DG, Cossman J, Myers CE, Cowan KH: Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 49: 1422-1428, 1989
26. Wallner J, Depisch D, Hopfner M, Haider K, Spona J, Ludwig H, Pirker R: MDR1 gene expression and prognostic factors in primary breast carcinomas. Eur J Cancer 27: 1352-1355, 1991
27. Akoury DA, Seo JJ, James D, Zaki SR: RT-PCR detection of mRNA recovered from archival glass slide smears. Mod Pathol 6: 195-200, 1992
28. Kovach JS, McGovern RM, Cassady JD, Swanson SK, Wold LE, Vogelstein B, Sommer SS: Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas. J Natl Cancer Inst 83: 1004-1009, 1991
29. Hermanek P, Sobin LH: UICC TNM Classification of Malignant Tumours. Springer-Verlag, Berlin, 1992
30. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
31. 2-microglobulin gene. Primary structure and definition of the transcription unit. J Immunol 139: 3132-3148, 1987
32. Chen C, Chin JE, Kazumitsu U, Clark DP, Pastan I, Gottesman MM, Roninson IB: Internal duplication and homology with bacterial transport proteins in mdr1 (P-glycoprotein) gene from multidrug-resistance human cells. Cell 47: 381-389, 1986
33. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in the immunoperoxidase techniques. J Histochem Cytochem 29: 577-580, 1981
34. Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andrueff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HSL, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Rimsza L, Roninson IB, Sikic BI, Twentyman PR, Warnke R, Weinstein R: Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendation. Cancer Res 56: 3010-3020, 1996
35. Murphy LD, Herzog CE, Rudick JB, Fojo AT, Bates SE: Use of the polymerase chain reaction in the quantification of mdr-1 gene expression. Biochemistry 29: 10351-10356, 1990
36. Hanson CA, Holbrook EA, Sheldon S, Schnitzer B, Roth MS: Detection of Philadelphia chromosome-positive cells from glass slide smears using the polymerase chain reaction. Am J Pathol 137: 1-6, 1990
37. Sanfilippo O, Ronchi E, De Marco C, Di Fronzo G, Silvestrini R: Expression of P-glycoprotein in breast cancer tissue and in vitro resistance lo doxorubicin and vincristine. Eur J Cancer 27: 155-158, 1991
38. Tascani A, Soprano DR, Cosenza SC, Owen TA, Soprano KJ: Normalization of multiple RNA samples using an in vitro-synthesized external standard cRNA. Anal Biochem 165: 309-319, 1987
39. Morello D, Duprey P, Israel A, Babinet C: Asynchronous regulation of mouse H-2D and beta-2-microglobulin RNA transcripts. Immunogenetics 22: 441-452, 1985
40. Bradley G, Naik M, Ling V: P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines. Cancer Res 49: 2790-2796, 1989
41. Hill BT, Deuchars K, Hosking LK, Ling V, Whelan RD: Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X̄ irradiation in vitro. J Natl Cancer Inst 82: 607-612, 1990
42. Slamon SE, Grogan TM, Miller T, Scheper R, Dalton WS: Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining. J Natl Cancer Inst 81: 696-701, 1989
43. Beck W: Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerase in drug action and resistance. J Natl Cancer Inst 81: 1683-1685, 1989
44. Keen JC, Miller EP, Bellamy C, Dixon JM, Miller W: P-glycoprotein and resistance to tamoxifen. Lancet 343: 1047-1048, 1994
45. Kacinski BM, Yee LD, Carter D, Li D, Kuo MT: Human breast carcinoma cell levels of MDR-1 (P-glycoprotein) transcripts correlate in vitro inversely and reciprocally with tumor progesterone receptor content. Cancer Commun 1: 1-6, 1989